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Abstract
Background: Infertility is defined as inability of a couple to conceive naturally after one year of regular
unprotected sexual intercourse. It remains a major clinical and social problem, affecting perhaps one couple in six.
Evaluation usually starts after 12 months; however it may be indicated earlier. The most common causes of
infertility are: male factor such as sperm abnormalities, female factor such as ovulation dysfunction and tubal
pathology, combined male and female factors and unexplained infertility.
Objectives: The aim of this study is to provide the healthcare professionals an evidence-based management
protocol for infertile couples away from medical information overload.
Methods: A comprehensive review where the literature was searched for “Management of infertility and/or infertile
couples” at library website of University of Bristol (MetaLib) by using a cross-search of different medical databases
besides the relevant printed medical journals and periodicals. Guidelines and recommendations were retrieved
from the best evidence reviews such as that from the American College of Obstetricians and Gynaecologists
(ACOG), American Society for Reproductive Medicine (ASRM), Canadian Fertility and Andrology Society (CFAS), and
Royal College of Obstetricians and Gynaecologists (RCOG).
Results: A simple guide for the clinicians to manage the infertile couples.
Conclusions: The study deploys a new strategy to translate the research findings and evidence-base
recommendations into a simplified focused guide to be applied on routine daily practice. It is an approach to
disseminate the recommended medical care for infertile couple to the practicing clinicians.
Background
Infertility is a common clinical problem. It affects 13%
to 15% of couples worldwide [1]. The prevalence varies
widely, being less in developed countries and more in
developing countries where limited resources for investi-
gation and treatment are available [2]. In the United
Kingdom, it is estimated that one in six couples would
complaint of infertility [3].
In addition, infertility is considered also a public pro-
blem. It does not affect the couples’ life only, but it also
affects the healthcare services and social environment
[4]. The feelings experienced by the infertile couples
include depression, grief, guilt, shame, and inadequacy
with social isolation.
Today, many patients do not receive the recom-
mended medical care that based on the best available
evidence [5]. As there is surplus medical information
everyday that can not be cached by healthcare providers,
clinical guidelines created to endorse up-to-date evi-
dence-based practice to improve patients’ outcome [6].
This study was carried out in accordance with the
requirements of the University of Bristol Regulations
and Code of Ethics for Research Programmes.
Methodology
This paper, as a comprehensive review, deploys a new
strategy to translate the research findings and evidence-
base recommendations into a simplified focused guide to
be applied on routine daily practice. It is an approach to
disseminate the recommended medical care of infertile
couple to the practicing clinicians. To accomplish this, the
literature was searched for the keywords of “Management
of infertility, infertile couples“ at library website of
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different medical databases such as ...Allied and Comple-
mentary Medicine Database (AMED), ...BIOSIS Previews
on Web of Knowledge, ...Cochrane Library, ...PubMed,
including Medline, and ...Web of Science, in-addition to
the relevant printed medical journals and periodicals.
Guidelines and recommendations were retrieved from the
best evidence reviews at the American College of Obstetri-
cians and Gynaecologists (ACOG), American Society for
Reproductive Medicine (ASRM), Canadian Fertility and
Andrology Society (CFAS), European Society of Human
Reproduction and Embryology (ESHRE), Human Fertilisa-
tion and Embryology Authority (HFEA), Royal College of
Obstetricians and Gynaecologists (RCOG), and the World
Health Organization (WHO).
Epidemiology of infertility
For healthy young couples, the probability of getting
pregnancy per a reproductive cycle is about 20% to 25%.
Their cumulative probabilities of conception are 60%
within the first 6 months, 84% within the first year, and
92% within the second year of regular fertility-focused
sexual activity.
Several studies have reported different causes of infer-
tility [7-9]. Some causes are more common in some
countries than others, such as pelvic inflammatory dis-
eases (PID) and sexually transmitted infections (STI) in
Africa [10]. Some personal habits are considered risk
factors for infertility, such as excess alcohol intake [11]
and cigarette smoking [12].
According to the literature survey, the most common
causes of infertility are: male factor [5,7-9,13-15] such as
sperm abnormalities [9,13,15], female factor [7-9,14-16]
such as ovulation dysfunction [7,8] and tubal pathology
[7-9], combined male and female factors [7,9,14,15] and
unexplained infertility; where no obvious cause could be
detected [7-9].
As the rate of getting spontaneous pregnancy among
infertile or subfertile couples is lower than that among
normal fertile population, it is recommended to carry
out the following diagnostic, evidence-based, work-up to
detect any hidden treatable cause.
History-taking
Couples with infertility problem should be interviewed
separately as well as together, to bring out important
facts that one partner might not wish to disclose to the
other. Full history taking of both partners usually
denotes the underlying problem [17-23], (Appendix 1).
Clinical examination
Full clinical examination of both partners usually stands
for the underlying physical problem [17-22,24-26],
(Appendix 2). By the end of this step, most of healthcare
professionals will be able to sketch out their provisional
diagnosis. Investigations will be requested to prove the
clinical diagnosis and to exclude other close possibilities.
Investigations
Infertile couples are usually adviced to start their inves-
tigations after 12 months of trying to conceive or after 6
months if the female partner is more than 35 years old
or immediately if there is an obvious cause for their
infertility or subfertility [16].
As the major causes of infertility are sperm abnormal-
ities, ovulation dysfunction, and fallopian tube obstruc-
tion, the preliminary adviced investigations for the
infertile couple should be focused on semen analysis (to
be compared with the WHO reference values [27]),
detection of ovarian function by hormonal assay (early
follicular FSH and LH levels, and mid-luteal progester-
one), and evaluation of tubal patency by hysterosalpin-
gography (HSG) [17-32], (Appendix 3).
Many infertile couples have had some previous assess-
ment for their infertility and this data should be cau-
tiously reviewed. Further investigations may be requested
according to the clinical presentation and the results of
preliminary tests. Omitting unnecessary investigations, in
particular couples, could reduce total cost of their inferti-
lity management without compromising their success
rate. For example; a woman who has no history sugges-
tive of previous pelvic inflammatory disease or endome-
triosis, there is no justification to request a laparoscopy
especially after normal hysterosalpingography study [33].
Similarly, there is no need for testing tubal patency for
couples who will require IVF or ICSI procedure.
A woman with a suspicion of chronic anovulation
most probably due to polycystic ovary (PCO) syndrome,
as there is a long history of irregular cycles and clinical
presentation with hirsutism, her serum levels of testos-
terone hormone, sex hormone binding globulin (SHBG),
dihydroepiandrostenedione (DHEA), dihydroepiandros-
tenedione-sulfate (DHEAS) and prolactin should be
evaluated to prove the provisional diagnosis and to
detect the source of excess androgens. However, early
referral of infertile couples to a dedicated specialist
infertility clinic may be indicated to increase their
chance of pregnancy (Table 1).
In some cases, the cause of infertility or subfertility
could not be suspected from the history taking and clin-
ical examination. In such circumstances, it is recom-
mended not to prescribe any medication until all basic
investigations are done and its results received.
Treatment
The cost of infertility treatment is high [34]. For this
reason, a call for low-cost ART protocols have been
attempt to reduce the overall current cost of IVF
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modifying the stimulation regimen and purchasing low-
priced pre-used machines and instruments [35]. But the
question that should be answered one day is: will the
output quality be compromised with such approach?
With the fast progression in reproductive medicine
and the experiences gained through infertility manage-
ment, a wider range of treatment options have become
available to infertile couples [17-19,21-26,31,36],
(Appendix 4). There are three main types of fertility
treatment: medical treatment (such as ovulation induc-
tion therapy); surgical treatment (such as laparoscopy
and hysteroscopy); and the different assisted reproduc-
tion techniques [37].
Choice of infertility treatment often related to issues
of efficacy, cost, ease of use or administration, and its
side effects. Legal, cultural and religious inquiries have
limited the available choices in some countries, such as
the use of donor sperms or oocytes.
Treatment options available for any particular infertile
couple will depend also on the duration of their inferti-
lity, which partner is affected, the age of the female
partner and if any has a previous children or not, the
underlying pathological cause, and if the treatment will
be covered by the National Health System (NHS) or
funded by their own.
Counseling
Fertility clinics should address the psycho-social and
emotional needs of infertile couples as well as their
medical needs. The content of counselling may differ
depending on the concerned couple and the existing
treatment options. It usually involves treatment implica-
tion counselling, emotional support counselling, and
therapeutic counselling [38,39].
Most of infertile couples are aware of what can be
o f f e r e dt ot h e mf r o mt h em e d i a. Regrettably, this often
leads to untruly high expectations of assisted reproduc-
tion techniques (ART) [40]. The chance of a live birth
following treatment is nearly 50% [25]. It varies with the
age (the optimal female age is between 23 and 39 years)
and with body weight (the ideal body mass index is
between 19 and 30). It is more successful in women
who have previously been pregnant. There is no reliable
means to predict whether the use of any treatment
option will be successful and after how many attempts.
The facilities available and the skills of personnel are
the major determining factors for the success rate.
An estimated 28% of all couples seeking reproductive
assistance may have normal findings on their clinical
evaluation, making the unexplained infertility a more
common provisional diagnosis. The predictable preg-
nancy rate for this group is about 5% after timed inter-
course, 10% after superovulation with intrauterine
insemination (IUI), and 15% to 25% after assisted repro-
duction techniques (ART) [41]. These rates, of course,
readjusted down for the older women with long dura-
tions of infertility [42].
As treatment begins, couples may experience cycles of
optimism and despair with each passing menstrual
Table 1 Criteria for early referral to specialist infertility clinic
In women In men
Age: < 35 years with > 18 months infertility. History of: Genital pathology
≥35 years with > 6 months infertility Uro-genital surgery
Sexually-transmitted infections
Varicocele
Cryptorchidism
Length of menstrual cycle: < 21 days. Systemic illness
> 35 days Chemotherapy/Radiotherapy
Menstrual abnormalities: Amenorrhoea
Oligomenorrhoea
History of: Ectopic pregnancy Two abnormal results of semen analysis:
Pelvic infections (PID) Sperm count < 20 million/ml
Endometriosis Sperm motility < 25% (grade-a)
Pelvic surgery (ruptured appendix) Sperm motility < 50% (grade-b)
Developmental anomalies Sperm morphology < 15% normal
Abnormal P/V findings on examination Abnormal findings on genital examination
Chlamydia antibody titre ≥ 1:256 Patient request or Anxiety
Mid-luteal progesterone < 20 nmol/l
FSH > 10 IU/l early follicular phase
LH > 10 IU/l early follicular phase
Patient request or Anxiety
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gical suffering is likely to increase [6]. The treating doc-
tor may feel inadequacy and the trust between the
doctor and patient breaks down [43]. At this point, psy-
chological consultation and support should be provided
[44].
The incidence of congenital malformation in IVF
babies ranges between 2% and 3% worldwide and is
similar to that in babies conceived naturally [45]. How-
ever there is a minimal increased risk of de-novo chro-
mosomal abnormalities in ICSI born babies [46,47] that
necessitate counselling of the concerned couples.
Conclusions
I n f e r t i l i t yb yi t s e l fd o e sn o tt h r e a t e nt h el i f e ,b u ti th a s
devastating psycho-social consequences on infertile cou-
ples. It remains a worldwide problem challenge. Man-
agement of infertility has been and still a difficult
medical task not only because of the difficulty in the
diagnosis and treatment of the reproductive disorders in
each partner, or the poorly unstated interaction between
the partners’ fertility potentials, but also because of the
fact that success of treatment is clearly identifiable
entity; the achievement of pregnancy. The treating doc-
tor who is counselling the couple regarding their inferti-
lity must be familiar with the causes, investigations and
the treatment options available. The couple needs to be
given realistic information about their chances of having
a live birth, as well as, the risks and costs of the man-
agement plan and its alternatives. By follow the pro-
posed, evidence-based, management protocol stated in
this paper, infertile couples will have a good chance to
start up their treatment in the proper way at early time
with enough financial support through reducing money
spent on unnecessay investigations.
Appendix 1. Focused history taking for infertile
couple
Female and Male Partners
Female Partner
Present history: the current problem/complaint, age,
occupation, recent cervical smear findings, breast
changes as milk-like discharges, excessive hair growth
with or without acne on face and chest, hot flushes, eat-
ing disorders, any current associated medical illness as
diabetes and/or hypertension, drug intake prescribed as
non-steroidal anti-inflammatory drugs (NSAIDs), sex
steroids and cytotoxic drugs or recreational as marijuana
and cocaine, smoking, alcohol, and caffeine consumption
Menstrual history: for age of menarche, cycle charac-
teristics and any associated symptoms as painful men-
struation or intermenstrual spotting. History of primary
or secondary amenorrhoea
Obstetric history: previous pregnancies, if any, and its
outcome, recurrent pregnancy loss, induced abortion,
post-abortive infection or puerperal sepsis
Contraceptive history: previous use of any contracep-
tive method, particularly intrauterine system, and any
associated problems
Sexual history: Coital frequency, timing in relation to
the cycle, use of vaginal lubricant before, or vaginal
douching after, coitus, loss of libido, as well as, any asso-
ciated problems as difficult or painful coitus
Past history: medical or surgical as pelvic infection,
tuberculosis, bilharziasis, ovarian cyst, appendicectomy,
laparotomy, caesarean sections, and cervical conization.
Ask about her rubella status
Family history: for similar problem among the female
members, consanguinity, diabetes mellitus, hypertension,
twins delivery, breast cancer
Male Partner
Present history: the current problem/complaint, age,
occupation, previous seminal analysis findings, breast
changes as enlargement, any current associated medical
illness as diabetes and/or hypertension, drug intake pre-
scribed or recreational, smoking, alcohol, and caffeine
consumption
Sexual history: Coital frequency, timing, and any
associated problems as erectile dysfunction or ejacula-
tory problems, loss of libido. History of previous mar-
riage or extra-marital sexual relations
Contraceptive history: previous use of any contracep-
tive method either temporary as condom or permanent
as vasectomy
Past history: medical disease or surgical operations as
mumps, tuberculosis, bilharziasis, sexually-transmitted
infections, hydrocele, varicocele, undescended testis,
appendicectomy, inguinal hernia repair, or bladder-neck
suspension operations
Family history: for similar problem among the male
members, consanguinity, diabetes mellitus, and
hypertension
Appendix 2. Focused clinical examination for
infertile couple
Female and Male Partners
Female Partner
General Examination: vital signs (especially blood
pressure), body height and weight (BMI= ratio between
weight in kilograms and height in square meters) for
over or under weights, secondary sexual characters,
a n ye x c e s s i v eh a i r sw i t h / w i t h o u ta c n eo nf a c eo rc h e s t ,
and acanthosis nigricans. Abnormal skin depigmenta-
tion as vitiligo may suggest an autoimmune systemic
disease. Examination should include also the thyroid
gland
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t oe x c l u d ea n yp a t h o l o g yo rp r e s e n c eo fo c c u l t
galactorrhoea
Chest Examination: for lungs and heart
Abdominal Examination: for any abdominal mass,
organomegaly, ascites, abdominal striae, and surgical
scars
Genital Examination: type of circumcision, size and
shape of clitoris, hymen, vaginal introitus, site, size,
shape, surface, consistency, mobility and direction of
uterus, any palpable adnexal mass, vaginal discharge,
tenderness, uterosacral ligament thickening, and nodules
in the cul-de-sac denoting either endometriosis or
tuberculosis by per-vaginal (PV) examination
Male Partner
General Examination: vital signs (especially blood
pressure), body height and weight (BMI), arm-span, sec-
ondary sexual characters, and examination of thyroid
gland.
Breast Examination: for gyanecomastia
Abdominal Examination: for any abdominal mass,
undescended testis, inguinal hernia, organomegaly, or
ascites
Genital Examination: shape and size of penis, pre-
puce, position of external urethral meatus, testicular
volume (by using Prader’s Orchidometer. Normally 25
ml = 3 × 5 cm), palpation of epididymis and vas defe-
rens, exclude varicocele or hydrocele. Perineal sensation,
rectal sphincter’s tone, and prostate enlargement by per-
rectal (PR) examination
Appendix 3. Focused investigations for infertile
couple
Female and Male Partners
Female Partner
Basic Investigations
General: Full blood count, urine analysis, Papanico-
laou smear, vaginal wet mount with appropriate culture,
Rubella serology, Hepatitis B and C, HIV serology, and
Chlamydia trachomatis serology
Hormonal assay: to predict ovulation and ovarian
reserve. Mid-luteal serum progesterone level (5-10 days
before the expected menstrual cycle). FSH, LH (twice if
female age > 38 years, on day 2-5 of the menstrual
cycle). The use of basal body temperature (BBT) chart-
ing and ovulation predictor home kits are not
recommended
Transvaginal ultrasonography: to monitor natural
ovulation, to detect any pelvic pathology as uterine or
ovarian masses, abnormally-shaped or mal-directed
uterus. No need for ultrasound scanning of
endometrium
Hysterosalpingography or Hysterosalpingo-Con-
trast-Sonography (HyCoSy):t oe v a l u a t es h a p eo f
uterine cavity and patency of both fallopian tubes in
low-risk women
Advanced Investigations
Hormonal assay: Prolactin (if cycles are irregular
with/without galactorrhoea or pituitary adenomas).
Thyroid function tests (for women with symptoms of
thyroid disease). Testosterone, SHBG, DHEA and
DHEAS (for suspected cases with PCO syndrome)
Laparoscopy: for possible associated pelvic pathology or
adhesions in cases with abnormal HSG findings, previous
history of pelvic inflammatory disease or endometriosis
Hysteroscopy: for intrauterine space-occupying
lesions detected on HSG as adhesions or polyp (no evi-
dence linking it with enhanced fertility)
Chromosomal karyotyping: for suspected genetic dis-
orders as Turner’s syndrome
Male Partner
Basic Investigations
General: Full blood count, Hepatitis B and C, HIV
serology, and Chlamydia trachomatis serology
Semen analysis (after 72 hours of sexual abstinence):
interpreted for its volume, sperm count, motility, and
morphology according to the WHO reference values
(Two analyses with 3 months apart at the same lab)
Advanced Investigations
Post-coital test: no predictive value on the pregnancy
rate
Anti-sperm antibodies (no evidence of effective treat-
ment to improve fertility), and Sperm function tests
Hormonal assay:F S H ,L H ,T e s t o s t e r o n e ,T S Ha n d
Prolactin (for male with abnormal seminal analysis and
suspected endocrine disorder)
Testicular biopsy: A fine-needle aspiration biopsy
may required to differentiate between obstructive and
non-obstructive azoospermia
Chromosomal karyotyping: for suspected genetic dis-
orders as sex chromosomal aneuploidy, cystic fibrosis,
and deletion of Y-chromosome
Appendix 4. Treatment Options for Infertile
couple
Female and Male Partners
Female Partner
Non-Invasive Treatment
Counselling: for regular intercourse 2-3 times/week.
Give-up smoking, not to drink more than 1-2 units of
alcohol/week, not to use any addictive drugs, and follow
a supervised weight loss programme if obese (BMI > 29).
Folic acid 0.4 mg should be provide as a daily supplement
to prevent neural tube defect (5.0 mg adviced for women
who have previously affected child or on medication for
epilepsy). Rubella vaccination if seronegative (avoid preg-
nancy for one month). Treat any psycho-sexual problem
if present
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dysfunctions. Provide a controlled ovarian stimulation
for assisted reproduction techniques
Intra-uterine Insemination (IUI):i sn o tr e g u l a t e db y
Human Fertilisation and Embryology Authority (HFEA)
in the United Kingdom. Could be used for unexplained
infertility and female cases with minimal endometriosis
Surrogacy: In women with congenital absence of
uterus or after surgical removal
Invasive Treatment
Tubal surgery: as laparoscopic adhesiolysis, tubal can-
nulation or catheterisation
Hysteroscopic surgery: as resection of IU adhesions
or polyp
In-vitro Fertilisation (IVF) and Embryo transfer
(ET): Used procedure for female tubal factor, moderate
male factor, and for unexplained infertility
Gamete Intra-fallopian Transfer (GIFT) and Zygote
Intra-fallopian Transfer (ZIFT): are not regulated by
HFEA. For cases who refuse fertilisation in lab
Oocyte donation and Ovarian tissue transplanta-
tion: for premature ovarian failure
Male Partner
Non-Invasive Treatment
Counselling: for regular intercourse 2-3 times/week,
give-up smoking, reduce alcohol intake to 3-4 units/
week, not to use any addictive drugs, wear loose fitting
underwear and trousers, and avoid occupational or
social situations that might cause testicular heating.
Treat any psycho-sexual problem if present
Intra-uterine Insemination (IUI): Used for mild male
factor infertility problems
Donor insemination: for azoospermia, positive HIV,
severe male factor who refuse the ICSI as a management
option
Adoption: For cases with recurrent unexplained failed
IVF cycles
Invasive Treatment
Surgical restoration of duct patency: For cases with
previous vasectomy
Intra-cytoplasmic Sperm Injection (ICSI) ± PGD:
Commonly used procedure for severe male factor or for
recurrent unexplained failed IVF cycles. Surgical sperm
retrieval (SSR) usually done by percutaneous epididymal
sperm aspiration (PESA), testicular sperm aspiration
(TESA), testicular sperm extraction (TESE), or micro-
surgical epididymal sperm aspiration (MESA).
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